P/E Ratio: Price to Earnings - Most used valuation metric
Analyzing Investment Quality
Processing 9 key metrics...
Loading shareholding data...
No insider trading data available
Standard pivot points - most widely used
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹177.17 | +₹19.52 | +12.38% |
| R3 | ₹169.77 | +₹12.12 | +7.69% |
| R2 | ₹167.08 | +₹9.43 | +5.98% |
| R1 | ₹162.37 | +₹4.72 | +2.99% |
| PIVOT | ₹159.68 | 2.03 | 1.29% |
| CURRENT | ₹157.65 | - | - |
| S1 | ₹140.17 | -₹17.48 | -11.09% |
| S2 | ₹147.57 | -₹10.08 | -6.40% |
| S3 | ₹152.28 | -₹5.37 | -3.40% |
| S4 | ₹154.97 | -₹2.68 | -1.70% |
is trading CPR, indicating
CPR is
Day's range: ~
Trading Inside opening range
| Company Name |
|---|
AksharChem (India) Ltd |
Asian Paints Ltd |
Hindcon Chemicals Ltd |
Hindprakash Industries Ltd |

Arvee Laboratories (India) Ltd. is a chemical manufacturing and distribution company based in Ahmedabad, India, established in 2012. Their primary business revolves around the production and sale of specialized chemicals both domestically within India and internationally through exports.
A significant portion of Arvee's product portfolio centers on polymer modifiers. These include a range of chemical compounds crucial in modifying the properties of polymers, enhancing their performance characteristics in various applications. Specific examples of these modifiers include dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate. The precise applications of these modifiers within the polymer industry are diverse and would require further technical detail to fully elaborate upon.
Another key area of Arvee's operations lies in the manufacturing of contrast media intermediates. These are chemical precursors used in the production of contrast agents, vital components in medical imaging techniques like X-rays and CT scans. The company produces a variety of these intermediates, including 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, dimethyl 5-aminoisophthalate, 3,5-dinitrobenzoic acid, and 3,5-diamino benzoic acid. This demonstrates a significant involvement in the pharmaceutical supply chain.
Furthermore, Arvee Laboratories also supplies drug intermediates. These are essential building blocks used in the synthesis of various pharmaceutical drugs. Their offerings in this category include 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4-aminopyridine, and 2-chloro-5-nitrobenzoic acid. This aspect of their business highlights their contribution to the broader pharmaceutical industry by providing crucial raw materials for drug manufacturing.
In summary, Arvee Laboratories is a key player in the specialty chemicals sector, serving both the polymer and pharmaceutical industries through the manufacturing and export of polymer modifiers, contrast media intermediates, and drug intermediates. Their diverse product portfolio and international reach solidify their position within the global chemical market.
403, Entice Building,, Opposite Jayantilal Park BRTS Bus Stop,, Iskcon Bopal Road, Ambli,
Ahmedabad
GUJARAT
IN
Tel: 912717430479
Website:http://arveelabs.com/
Group: Materials
Sector: Materials
Industry: Chemicals
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 65
IPO Date: 22/02/2018
Mr. Maulesh Raval
Chief Financial Officer
Ms. Neelam Chotrani
Company Secretary & Compliance Officer
Shri. Shalin Patel
Managing Director, Director
Mr. Saurin Gandhi
Additional Director
Mr. Praveen Mishra
Additional Director
Mr. Saumil Chokshi
Non-Executive Director
Ms. Chandrakala Bhatt
Additional Non-Executive Independent Director
Mr. Vishal Mehta
Additional Non-Executive Independent Director
Mr. Amishkumar Shah
Additional Non-Executive Independent Director
Get answers to the most common questions about Arvee Laboratories (India) Ltd stock price, fundamentals, financial metrics, and investment analysis
Explore peers, sector trends and screeners related to this stock.